Jazz Pharmaceuticals plc announced that the National Institute for Health and Care Excellence (NICE) has publ...
AbbVie has announced patent license agreements with Momenta over its proposed biosimilar adalimumab product. Under the t...
Oncology Analytics, a leading technology-enabled service company which provides health plans, providers and patients wit...
A group of scientists from Rutgers University-New Brunswick Rutgers has created a tiny, biodegradable scaffold to transp...
Merck, the vibrant science and technology company, has launched its new BioContinuum Platform to advance biotherapeutic ...
Genetics can be used to predict a patient's response to antipsychotic drug treatment for schizophrenia, according to a r...
Singapore - In the future, cyberattackers may be able to exploit memory implants to steal, spy on, alter or control huma...
Pfizer recently announced that the U.S. Food and DrugAdministration (FDA) has aproved LORBRENA a third-generation ...
Amsterdam-based BioGX B.V., a subsidiary of Birmingham, Alabama based molecular diagnostics company BioGX, ann...
Agilent Technologies Inc. has introduced the Cary 3500 UV-Vis system, an innovative spectrophotometer designed to help l...
Sandoz, a Novartis division and the pioneer and global leader in biosimilars, has announced that the US Food and Drug Ad...
Singapore - The FDA approves a consumer-targeted molecular diagnostic test from privately held 23andme, t...
The US FDA is taking new steps to foster innovation in the emerging space of plant and animal biotechnology. The FDA has...
OpGen, Inc. has announced a collaboration with QIAGEN N.V. to advance rapid diagnostics for antimicrobial resistance (AM...
Orchard Therapeutics plc a biopharmaceutical company dedicated to transforming the lives of patients with serious and li...
Singapore – The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and D...
Singapore – Halozyme has out-licensed its ENHANZE drug delivery technology to Roche for the exclusi...
Informa plc has appointed Adam Andersen Group Director of the Pharma Portfolio (previously part of UBM), which includes ...
